CDK4/6 inhibition in luminal breast cancer.

Simon Peter Gampenrieder* (First author), Gabriel Rinnerthaler (Co-author), Richard Greil (Last author)

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

10 Citations (Web of Science)
Original languageEnglish
Pages (from-to)76-81
Journalmemo - Magazine of European Medical Oncology
Volume9
DOIs
Publication statusPublished - 2016

Keywords

  • KINASE 4/6 INHIBITOR
  • PALBOCICLIB
  • RESISTANCE
  • MECHANISMS
  • THERAPY

Cite this